Rainbow Trout IgM+ B Cells Preferentially Respond to Thymus-Independent Antigens but Are Activated by CD40L

被引:19
|
作者
Granja, Aitor G. [1 ]
Perdiguero, Pedro [1 ]
Martin-Martin, Alba [1 ]
Diaz-Rosales, Patricia [1 ]
Soleto, Irene [1 ]
Tafalla, Carolina [1 ]
机构
[1] Anim Hlth Res Ctr CISA INIA, Madrid, Spain
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
基金
欧洲研究理事会;
关键词
teleost fish; B cells; IgM; extrafollicular responses; CD40L; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; ONCORHYNCHUS-MYKISS; GENE-EXPRESSION; PLASMA-CELLS; MEMORY; LYMPHOCYTES; LIGAND; IDENTIFICATION; PATHWAY;
D O I
10.3389/fimmu.2019.02902
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the absence of class switch recombination and germinal centers, the mechanisms through which B cells from teleost fish mount extrafollicular immunoglobulin M (IgM) memory responses remains mostly unexplored. In this report, we demonstrate that teleost IgM(+) B cells respond to CD40L, a thymus-dependent activation signal, similarly to mammalian B2 cells. However, when stimulated with different types of antigens, fish IgM(+) B cells only reach a general activation state in response to antigens cataloged as thymus-independent 1 (TI-1) in mammals, as established through both functional assays and RNA sequencing. Interestingly, fish IgM(+) B cells remained completely unresponsive to TI-2 antigens, suggesting that the engagement of innate receptors provided by TI-1 antigens is required for the activation of teleost B cells. Finally, a synergy between CD40L and TI-1 antigens was also demonstrated, further supporting that there is no clear dichotomy between thymus-dependent and TI responses in teleost fish.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Induction of apoptosis in B lymphoma cells by activation with CD40L
    Lefterova, P
    Märten, A
    Buttgereit, P
    Schakowski, F
    Micka, B
    Scheffold, C
    Schmidt-Wolf, IGH
    ACTA HAEMATOLOGICA, 2000, 103 (03) : 168 - 171
  • [22] The interaction of CD40 receptor on B cells with different forms of recombinant CD40L
    Byazrova, M.
    Astakhova, E.
    Spiridonova, A.
    Prilipov, A.
    Filatov, A.
    FEBS OPEN BIO, 2021, 11 : 218 - 218
  • [23] ACTIVATION OF ANTIGEN-ENRICHED B-CELLS .1. PURIFICATION AND RESPONSE TO THYMUS-INDEPENDENT ANTIGENS
    SNOW, EC
    VITETTA, ES
    UHR, JW
    JOURNAL OF IMMUNOLOGY, 1983, 130 (02): : 607 - 613
  • [24] DIFFERENTIAL EFFECT OF ACTIVATED T-AMPLIFIER CELLS ON B-CELLS RESPONDING TO THYMUS-INDEPENDENT TYPE-1 AND TYPE-2 ANTIGENS
    BRALEYMULLEN, H
    JOURNAL OF IMMUNOLOGY, 1982, 129 (02): : 484 - 489
  • [25] THE EXPRESSION OF SURFACE IGD ON B-CELLS RESPONSIVE TO THYMUS-INDEPENDENT AND THYMUS-DEPENDENT ANTIGENS AND ITS REQUIREMENT FOR B-CELL TRIGGERING
    MARSHALLCLARKE, S
    KEELER, KD
    PARKHOUSE, RME
    IMMUNOLOGY, 1983, 48 (02) : 393 - 400
  • [26] CD40L induces differentiation of chicken B cells towards plasma cells
    Schumacher, M.
    Morgenroth, I.
    Young, J.
    Kaspers, B.
    Kothlow, S.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 184 - 185
  • [27] CD86 signaling on a CD40L/IL-4-activated B cell
    Kin, NW
    Sanders, VM
    FASEB JOURNAL, 2005, 19 (04): : A953 - A953
  • [28] RISE IN INULIN-SENSITIVE B-CELLS DURING ONTOGENY CAN BE PREMATURELY STIMULATED BY THYMUS-DEPENDENT AND THYMUS-INDEPENDENT ANTIGENS
    SHAHIN, RD
    CEBRA, JJ
    INFECTION AND IMMUNITY, 1981, 32 (01) : 211 - 215
  • [29] CD40/CD40L interactions and cytokines regulate HIV replication in B cells in vitro
    Gras, G
    Legendre, C
    Krzysiek, R
    Dormont, D
    Galanaud, P
    Richard, Y
    VIROLOGY, 1996, 220 (02) : 309 - 319
  • [30] CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
    Naito, Masayasu
    Hainz, Ursula
    Burkhardt, Ute E.
    Fu, Buyin
    Ahove, Deborah
    Stevenson, Kristen E.
    Rajasagi, Mohini
    Zhu, Baogong
    Alonso, Anselmo
    Witten, Elizabeth
    Matsuoka, Ken-ichi
    Neuberg, Donna
    Duke-Cohan, Jonathan S.
    Wu, Catherine J.
    Freeman, Gordon J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (02) : 347 - 357